These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11902547)

  • 1. Mosaic tumour blood vessels and high-dose chemotherapy for breast cancer.
    Bertolini F; Martinelli G; Goldhirsch A
    Lancet Oncol; 2001 Oct; 2(10):595. PubMed ID: 11902547
    [No Abstract]   [Full Text] [Related]  

  • 2. Mosaic vessels shed cancer clues by the million.
    Stephenson J
    Lancet Oncol; 2001 Mar; 2(3):130. PubMed ID: 12001889
    [No Abstract]   [Full Text] [Related]  

  • 3. Measuring circulating tumor cells as a surrogate end point for adjuvant therapy of breast cancer: what do they mean and what should we do about them?
    Bear HD
    J Clin Oncol; 2008 Mar; 26(8):1195-7. PubMed ID: 18323543
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological and clinical considerations regarding the use of surgery and chemotherapy in the treatment of primary breast cancer.
    Fisher B
    Cancer; 1977 Jul; 40(1 Suppl):574-87. PubMed ID: 328138
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating tumour cells in cancer patients: challenges and perspectives.
    Pantel K; Alix-Panabières C
    Trends Mol Med; 2010 Sep; 16(9):398-406. PubMed ID: 20667783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritumoral vascular invasion in women with node-negative breast cancer, receiving no adjuvant therapy.
    Mathoulin-Portier MP; Meynard P; Charton-Bain MC; Escoute M; Bardou VJ; Puig B; Viens P; Cowen D; Houvenaeghel G; Hassoun J; Jacquemier J
    Anticancer Res; 1999; 19(1B):843-7. PubMed ID: 10216503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer.
    Hartkopf AD; Wagner P; Wallwiener D; Fehm T; Rothmund R
    Anticancer Res; 2011 Mar; 31(3):979-84. PubMed ID: 21498725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary fibroelastoma of the left heart with multiple origins?
    Yerebakan C; Steinhoff G; Skrabal CA
    Interact Cardiovasc Thorac Surg; 2010 Nov; 11(5):677-8. PubMed ID: 20962168
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical utility of circulating tumor cells in metastatic breast cancer.
    Bidard FC; Pierga JY
    J Clin Oncol; 2015 May; 33(14):1622. PubMed ID: 25870091
    [No Abstract]   [Full Text] [Related]  

  • 10. A proposed mechanism for the pathogenesis of multiple primary tumours.
    He H; Zhao D; Liu M; He Z
    Med Hypotheses; 2009 Oct; 73(4):624-5. PubMed ID: 19640653
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating tumor cells in breast cancer: fiction or reality?
    Cristofanilli M; Reuben J; Uhr J
    J Clin Oncol; 2008 Jul; 26(21):3656-7; author reply 3657-8. PubMed ID: 18640950
    [No Abstract]   [Full Text] [Related]  

  • 12. Migrating and circulating breast carcinoma cells are within active phases of the cell cycle.
    Kubens BS; Feldner JC; Brandt B; Zänker KS
    Anticancer Res; 2002; 22(2A):899-903. PubMed ID: 12014669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating and disseminated tumor cells.
    Braun S; Naume B
    J Clin Oncol; 2005 Mar; 23(8):1623-6. PubMed ID: 15755968
    [No Abstract]   [Full Text] [Related]  

  • 14. Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
    Bozionellou V; Mavroudis D; Perraki M; Papadopoulos S; Apostolaki S; Stathopoulos E; Stathopoulou A; Lianidou E; Georgoulias V
    Clin Cancer Res; 2004 Dec; 10(24):8185-94. PubMed ID: 15623593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumour cells in breast cancer.
    Ring A; Smith IE; Dowsett M
    Lancet Oncol; 2004 Feb; 5(2):79-88. PubMed ID: 14761811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.
    Pierga JY; Bidard FC; Mathiot C; Brain E; Delaloge S; Giachetti S; de Cremoux P; Salmon R; Vincent-Salomon A; Marty M
    Clin Cancer Res; 2008 Nov; 14(21):7004-10. PubMed ID: 18980996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autopsy case of intravascular lymphomatosis with pancreatic carcinoma].
    Komada F; Yamashita Y; Kawabata H; Yazaki A; Kobayashi K; Tanaka I; Otsuji A; Yokoyama N; Ohno T
    Rinsho Ketsueki; 1999 May; 40(5):423-6. PubMed ID: 10390893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assays that predict outcomes make slow progress toward prime time.
    Schmidt C
    J Natl Cancer Inst; 2010 May; 102(10):677-9. PubMed ID: 20460635
    [No Abstract]   [Full Text] [Related]  

  • 19. Great vessel/cardiac extension and tumor embolism in pleuropulmonary blastoma: a report from the International Pleuropulmonary Blastoma Registry.
    Priest JR; Andic D; Arbuckle S; Gonzalez-Gomez I; Hill DA; Williams G
    Pediatr Blood Cancer; 2011 Apr; 56(4):604-9. PubMed ID: 21298746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of the "vascular invasion" factor for prognosis of breast cancer].
    Kurz C; Obermair A; Nagele F; Czerwenka K; Schemper M; Kubista E; Sevelda P
    Geburtshilfe Frauenheilkd; 1994 May; 54(5):295-9. PubMed ID: 8050691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.